Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
moroctocog alfa + isopropyl alcohol
- Development stage
- Unknown
- Lead developer
- Pfizer
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous, Topical
01
Overview
Moroctocog alfa + isopropyl alcohol refers to a packaged drug-product listing in which the therapeutic active drug is **moroctocog alfa**, a recombinant B-domain deleted human coagulation factor VIII used for replacement therapy in hemophilia A, while **isopropyl alcohol** reflects a kit-associated antiseptic component such as alcohol swabs rather than a co-active systemic ingredient. Moroctocog alfa functions by replacing deficient factor VIII and restoring the intrinsic coagulation cascade through participation in the factor IXa-mediated activation of factor X, thereby promoting thrombin generation and clot formation in patients with congenital factor VIII deficiency. Commercially this corresponds to moroctocog alfa products such as Xyntha and ReFacto AF that are supplied as intravenous lyophilized recombinant factor VIII kits for on-demand bleeding control, perioperative management, and routine prophylaxis in hemophilia A.
- Brand names
- Xyntha
- Other names
- moroctocog alfa + isopropyl alcohol
02
Targets
PS (Phosphatidylserine)F10 (Factor Xa)Coagulation Factor IXa
Beyond the preview
Go deeper on moroctocog alfa + isopropyl alcohol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on moroctocog alfa + isopropyl alcohol.